Is a
Patent attributes
Patent Jurisdiction
Patent Number
Date of Patent
October 11, 2022
Patent Application Number
16989211
Date Filed
August 10, 2020
Patent Citations
Patent Primary Examiner
The present invention relates to compounds which may be useful as inhibitors of PTPN11 for the treatment or prevention of cancer and other PTP-mediated diseases. Disclosed herein are new compounds and compounds based on pyrazolopyrazines and their application as pharmaceuticals for the treatment of disease.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
